Hydration Pharmaceuticals Achieves First Positive Cash Flow

Hydration Pharmaceuticals Co. Ltd. (AU:HPC) has released an update.

Hydration Pharmaceuticals Co. Ltd. (ASX: HPC) reported its first positive operating cash flow of $0.6 million in Q3 FY24, driven by a strong focus on profitability and cost reduction. The company achieved $2.4 million in revenue, with significant contributions from e-commerce sales, and reduced its EBITDA loss by 54% year-over-year. Additionally, the divestiture of non-US assets provided $9.5 million in proceeds, allowing the company to focus on scaling its US operations and e-commerce channels.

For further insights into AU:HPC stock, check out TipRanks’ Stock Analysis page.